Lou Ruvo Center for Brain Health, 888 W. Bonneville Avenue, Las Vegas, NV 89106
Fees:
Please check the event's website for more information
Sponsor(s):
Practitioners who attend the course will be provided with the latest assessment and treatment updates on Alzheimer's, Frontotemporal, Lewy body, vascular and other dementias.
Sheraton Crystal City Hotel, 1800 Jefferson Davis Highway, Arlington, VA 22202
Fees:
Please visit the event's website for more information
Sponsor(s):
Plenary and panel sessions at this conference will include presentations on the following key subject areas: Classification, diagnostics, imaging and outcomes research.
HIlton San Francisco Financial District, 740 Kearny Street, San Francisco, CA 94108
Fees:
please visit the event's website for more information
Sponsor(s):
Topics that will be covered in this conference include updates on biomarkers in Alzheimer's disease, Parkinson's disease, and the frontotemporal dementias. More information may be found at:
National Institutes of Health, 9000 Rockville Pike, Bethesda MD 20892
Fees:
Please check the program's website for more information
Sponsor(s):
New investigators to the field of Alzheimer's disease research are encouraged to apply for a 6-day workshop that will be focused on current issues, research methodologies and funding opportunities in the field. Applicants focusing on health disparities research are encouraged to apply!
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich Street, 40th Floor, New York, NY 10007
Fees:
Please check the event's website for more information
Sponsor(s):
This symposium highlights the role of insulin resistance in Alzheimer's disease (AD), and explores the current status of clinical trials using insulin and insulin-sensitizing drugs for the treatment of AD.
Hilton Hotel Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852
Fees:
Please contact the event's organizers for more details
Sponsor(s):
The primary goal of this meeting will be to explore collaborative partnerships in the development of combination therapies for Alzheimer's disease (AD). The Food and Drug Administration (FDA)'s draft guidance on the development of multiple therapies in combination for AD treatment will also be discussed.
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich Street, 40th Floor, New York, NY 10007
Fees:
Please check the event's website for more information
Sponsor(s):
Presented by the New York Academy of Sciences, presenters will discuss the 'Metal Hypothesis of Neurodegenerative Diseases' and include a review the early clinical experience of the PBT2 compound.
Miami Beach Resort, 4833 Collins Avenue, Mami Beach, FL 33140
Fees:
Please check the event's website for more information
Sponsor(s):
The event's theme will focus on the progression rates from normal to mild cognitive impairment and then to dementia. The symposium itself will be held on January 19, while a workshop and a public education form on early Alzheimer's disease will be held on January 20.
Georgetown University Hotel and Conference Center, 1 Leavey Center, Washington, DC 20057
Fees:
None
Sponsor(s):
Funded by an NIH/NIA program project grant (P01 AG030128), this annual symposium will feature keynote presentations by Bradley T. Hyman, MD, PhD, of the Massachusetts Alzheimer's Disease Research Center and Robert W. Mahley, MD, PhD, of The Gladstone Institutes.
